Introducing Biotechnology by Amgen
Considered a worldwide leader in the research, development, and manufacturing of complex biological therapies, Amgen has a record of reliably delivering high-quality medicines to patients. Amgen launched the Biotechnology by Amgen program to share our commitment to quality and reliable supply with physicians, pharmacists, payers, and policymakers.
“At Amgen, robust quality assurance and control and a reliable supply are every bit as important to us as scientific innovation,” said Madhu Balachandran, executive vice president of Operations. “That’s why we make significant investments in our state-of-the-art manufacturing facilities, and have robust processes and an experienced and engaged workforce.”
Biotechnology by Amgen demonstrates Amgen’s decades of manufacturing, quality assurance and quality control experience, and commitment to the goal of delivering high-quality and reliably available medicines to every patient, every time. The program provides a number of resources including a website, www.biotechnologybyamgen.com , where visitors can take a virtual tour of Amgen’s manufacturing processes and view videos of Amgen staff discussing how Amgen builds quality into medicines from the start, helps ensure a reliable supply, and innovates in manufacturing. Advertising will encourage physicians, pharmacists, payers, and policymakers to visit the website and learn more.
click image to enlarge